Download presentation
Presentation is loading. Please wait.
Published byJodie Parrish Modified over 6 years ago
1
Copyright © 2003 American Medical Association. All rights reserved.
From: Idiopathic Orbital InflammationDistribution, Clinical Features, and Treatment Outcome Arch Ophthalmol. 2003;121(4): doi: /archopht Figure Legend: Frequency of symptoms and signs of idiopathic orbital inflammation. Date of download: 10/29/2017 Copyright © 2003 American Medical Association. All rights reserved.
2
Copyright © 2003 American Medical Association. All rights reserved.
From: Idiopathic Orbital InflammationDistribution, Clinical Features, and Treatment Outcome Arch Ophthalmol. 2003;121(4): doi: /archopht Figure Legend: Frequency of treatment outcomes for different subtypes of orbital pseudotumor. Success is complete resolution of symptoms at the time of the last follow-up. Failure is partial or no resolution of symptoms at the time of the last follow-up. Date of download: 10/29/2017 Copyright © 2003 American Medical Association. All rights reserved.
3
Copyright © 2003 American Medical Association. All rights reserved.
From: Idiopathic Orbital InflammationDistribution, Clinical Features, and Treatment Outcome Arch Ophthalmol. 2003;121(4): doi: /archopht Figure Legend: Frequency of treatment outcome for different treatment modes. Success is complete resolution of symptoms at the time of the last follow-up. Failure is partial or no resolution of symptoms at the time of the last follow-up. NSAIDs indicates nonsteroidal anti-inflammatory drugs. Date of download: 10/29/2017 Copyright © 2003 American Medical Association. All rights reserved.
4
Copyright © 2003 American Medical Association. All rights reserved.
From: Idiopathic Orbital InflammationDistribution, Clinical Features, and Treatment Outcome Arch Ophthalmol. 2003;121(4): doi: /archopht Figure Legend: The frequency of patients with steroid intolerance (adverse reaction to steroid therapy) and steroid dependence(recurrence of or increase in symptoms during or after steroid taper) is shown for each treatment outcome. Success is complete resolution of symptoms at the time of the last follow-up. Failure is partial or no resolution of symptoms at the time of the last follow-up. Date of download: 10/29/2017 Copyright © 2003 American Medical Association. All rights reserved.
5
Copyright © 2003 American Medical Association. All rights reserved.
From: Idiopathic Orbital InflammationDistribution, Clinical Features, and Treatment Outcome Arch Ophthalmol. 2003;121(4): doi: /archopht Figure Legend: Algorithm for decision pathways in the diagnosis and treatment of idiopathic orbital inflammation. ACE indicates angiotensin-converting enzyme; ANCA, antineutrophil cytoplasmic antibody; CBC, complete blood count; CT, computed tomography; MRI, magnetic resonance imaging; and NSAIDs, nonsteroidal anti-inflammatory drugs. Date of download: 10/29/2017 Copyright © 2003 American Medical Association. All rights reserved.
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.